Skip to content

LB Pharmaceuticals Inc

LBRX· Nasdaqxbrl foundCIK 1691082

Pharmaceutical preparations552 peers

Last sale
Nov 2, 2026 · -1.54%
Market cap
$1.26B
32.27M shares
Filings
146
—
—
—
-$59.07M
Q3 2026N/M FY25 yoy
—
—
—
-$125.68M
Q3 2026derivedN/M FY25 yoy
-$1.79
Q3 2026N/M FY25 yoy
$215.08M
Q3 2026+988.8% FY25 yoy
$1.26B
—
—
3.0×
-2.80%
—

FY2025 figures · derived

Price

$39.07+141.62%+$22.90past year
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$16.74MFY 2025
$51.17M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$16,744,000reported
FY 20242024-12-31$51,171,000reported

Pharmaceutical preparations

LB Pharmaceuticals Inc is the 135th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

LB Pharmaceuticals Inc · CIK 1691082 · Engraved from SEC EDGAR